Retour
Prix NervGen Pharma Corp. (NGENF)
Graphique du cours de l'action NGENF
NGENF Prix
NervGen Pharma Corp.
$5.22
0.19%
$0
À la fermeture : Jan 23, 16:00:00 GMT-5
$5.22
0%
$0
Post-Marché: Jan 23, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$5.21
Prix d'ouverture
$5.25
Plage de la journée
$5.11 - $5.38
Plage de 52 semaines
$1.5 - $6.3
Volume
62.4K
Volume moyen
143.3K
BPA (TTM)
-0.26
Rendement en dividend
--
Capitalisation boursière
$413.4M
Qu’est-ce que NervGen Pharma Corp. ?
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
